Lentivirus vector shows promise as potential treatment for Duchenne muscular dystrophy (IMAGE)
Caption
Researchers showed that systemic delivery of Mymk+Mymg-LV-Dys resulted in a significant level of Dys+ myofibers. Importantly, the team did not detect evidence of viral transduction in non-skeletal muscle tissues including heart, kidney, liver, and spleen. Dystrophic mice exhibited healthier muscles (reductions in muscles cells where a dye was able to enter) after treatment with Mymk+Mymg-LV-Dys.
Credit
Cincinnati Children's Hospital Medical Center
Usage Restrictions
none
License
Original content